Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G1EE
|
|||
| Former ID |
DIB000838
|
|||
| Drug Name |
ATRINOSITOL
|
|||
| Synonyms |
Atrinositol; Atrinositol [INN]; UNII-VYF3049W3N; VYF3049W3N; D-myo-Inositol 1,2,6-tris(dihydrogen phosphate); 28841-62-5; PP56; alpha-Trinositol; AC1L23WT; SCHEMBL636077; Inositol 1,2,6-triphosphate; CHEMBL2106016; myo-inositol 1,2,6-triphosphate; GKDKOMAJZATYAY-UOTPTPDRSA-N; GKDKOMAJZATYAY-GCVPSNMTSA-N; PP-56; C6H15O15P3; D-myo-inositol-126-triphosphate; ZINC71789368; LS-84057; D-chiro-Inositol 1,2,6-trisphosphoric acid; D-myo-Inositol-1,2,6-tris(hydrogen phosphate)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Discontinued in Phase 2 | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H15O15P3
|
|||
| Canonical SMILES |
C1(C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)O
|
|||
| InChI |
1S/C6H15O15P3/c7-1-2(8)4(19-22(10,11)12)6(21-24(16,17)18)5(3(1)9)20-23(13,14)15/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1?,2-,3+,4-,5-,6?/m1/s1
|
|||
| InChIKey |
GKDKOMAJZATYAY-GCVPSNMTSA-N
|
|||
| CAS Number |
CAS 28841-62-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
4466, 584598, 585449, 820601, 821278, 821742, 827190, 827943, 828882, 841121, 6436716, 7888275, 7979616, 8143490, 10298344, 14929378, 24424446, 26703584, 26704465, 26708401, 36883676, 46391586, 46392067, 46392501, 46392577, 49661706, 53787787, 57403035, 57646595, 76320031, 103181737, 103968356, 104620555, 125165392, 126524098, 127346574, 127346575, 127346576, 128618654, 134351980, 134352311, 135668526, 137178736, 162163996, 170495034, 175605264, 178101039, 183813901, 221121958, 221121963
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4222). | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000015) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.